17Lu-DOTATATE

¹⁷Lu-DOTATATE is a type of peptide receptor radionuclide therapy that for the treatment of somatostatin receptor-positive gastroenteropancreatic (GEP) neuroendocrine tumor (NET) patients.

Virtual price, please inquire if needed.

We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.

msds of 17Lu-DOTATATE